Dr Lan-Lan Smith is the founding Editor-in-Chief of The Lancet Haematology, launching the journal in 2014. She earned her PhD from Cancer Research UK/University College London, UK, in acute myeloid leukaemia genetics and held post-doctoral research posts in the Haemato-Oncology Section at the Institute of Cancer Research, UK, and in the Department of Haematology-Oncology at King's College London, London, UK, before joining The Lancet group as a Senior Editor at The Lancet Oncology in 2011.

Dr. Drew Provan is Emeritus Reader in Autoimmune Haematology at Barts and The London School of Medicine and Dentistry. He originally studied molecular genetics before training in medicine, and later undertook research at the Dana–Farber Cancer Institute in Boston as an MRC Travelling Fellow. Dr Provan is a leading authority in immunohaematology, with a major focus on immune thrombocytopenia, neutropenia and haemolytic anaemia. He helped establish the UK ITP Registry and is a senior author of the International Consensus Guidelines for the diagnosis and management of ITP in adults and children. He has published extensively in the field and is author of several well-known medical texts, including Molecular Haematology, the Oxford Handbook of Clinical Haematology, and the ABC of Clinical Haematology.